Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Russell Taylor Sundby

Has grant

Assistant Professor

Thomas Jefferson University

United States

Research Interests

Explore related searches

Professors in United States Professors in Biostatistics Biostatistics professors in United States

Recent Grants

Grant: Close

Dissecting the circulating proteome in NF1-associated peripheral nerve sheath tumors.

Open Date: 2022-11-01

Close Date: 2024-10-01

Grant: Close

Multi-omic liquid biopsy analysis for early detection of malignant transformation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 (NF1)

Open Date: 2022-07-01

Close Date: 2025-06-01

Grant: Close

A Pilot Study Incorporating Prospective PET-CT Imaging with Peripheral Blood Next-Generation Sequencing and Cell-Free DNA to Identify and Optimize Outcomes of CAR T-cell Therapy in Extramedullary B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Open Date: 2022-07-01

Close Date: 2023-07-01

Grant: Close

Cell free DNA analysis for early detection of malignant transformation in patients with neurofibromatosis type 1 (NF1)

Open Date: 2020-11-01

Close Date: 2021-11-01

Articles (14)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (15)

Sharon Savage

Clinical Director

National Cancer Institute

UNITED STATES

Russell Taylor Sundby

Research Interests

Explore related searches

Recent Grants

Articles (14)

New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis

SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)

A Pilot Study of Plasma Cell-Free DNA Fragmentomics in Gallbladder Cancer

Rare cancers research: current state of knowledge and emerging opportunities for prevention and interception

Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series

Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

Brain Metastasis in Pediatric Patients with Osteosarcoma

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients

Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.

MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors

Collaborators (15)

Sharon Savage

Brendan C. Dickson

Paul Jones

Jeffrey Szymanski

Clemens Oliver Hanemann

Andrea Gross

John Ligon

Brian Ladle

Jack Shern

Pradeep Chauhan

Adam Levin

Scott Plotkin

Vanessa Merker

Amy Armstrong

Rosandra Kaplan

Make your next move.